Karen Rowan

663 total citations
29 papers, 430 citations indexed

About

Karen Rowan is a scholar working on Oncology, Molecular Biology and Immunology and Allergy. According to data from OpenAlex, Karen Rowan has authored 29 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Immunology and Allergy. Recurrent topics in Karen Rowan's work include Cell Adhesion Molecules Research (7 papers), Peptidase Inhibition and Analysis (6 papers) and Biochemical and Structural Characterization (5 papers). Karen Rowan is often cited by papers focused on Cell Adhesion Molecules Research (7 papers), Peptidase Inhibition and Analysis (6 papers) and Biochemical and Structural Characterization (5 papers). Karen Rowan collaborates with scholars based in United States and Switzerland. Karen Rowan's co-authors include Mark David, Frank Podlaski, Kuo‐Sen Huang, Xiaolei Zhang, Shirley Xin Li, Charles Wartchow, Jefferson Tilley, Richard Trilles, Robert M. Campbell and Barry A. Wolitzky and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Karen Rowan

28 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen Rowan United States 13 201 88 73 71 50 29 430
Mary Pat Beavers United States 17 408 2.0× 63 0.7× 192 2.6× 69 1.0× 102 2.0× 25 729
Thomas H. Marsilje United States 14 247 1.2× 64 0.7× 118 1.6× 10 0.1× 26 0.5× 21 433
Dana Davis United States 12 238 1.2× 46 0.5× 161 2.2× 13 0.2× 13 0.3× 16 571
Gary P. Hingorani United States 11 163 0.8× 56 0.6× 48 0.7× 32 0.5× 13 0.3× 17 433
Stefan Jaroch Germany 14 228 1.1× 105 1.2× 244 3.3× 22 0.3× 21 0.4× 24 843
Geeta Patel United Kingdom 18 288 1.4× 166 1.9× 224 3.1× 10 0.1× 21 0.4× 45 732
Christophe Henry France 12 160 0.8× 158 1.8× 100 1.4× 32 0.5× 58 1.2× 25 459
Vesna Schauer-Vukašinović United States 11 242 1.2× 93 1.1× 126 1.7× 4 0.1× 35 0.7× 17 447
Philbert Lee United States 8 323 1.6× 115 1.3× 56 0.8× 37 0.5× 27 0.5× 9 503
Heather M. Brechbuhl United States 13 413 2.1× 345 3.9× 46 0.6× 14 0.2× 12 0.2× 17 807

Countries citing papers authored by Karen Rowan

Since Specialization
Citations

This map shows the geographic impact of Karen Rowan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Rowan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Rowan more than expected).

Fields of papers citing papers by Karen Rowan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Rowan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Rowan. The network helps show where Karen Rowan may publish in the future.

Co-authorship network of co-authors of Karen Rowan

This figure shows the co-authorship network connecting the top 25 collaborators of Karen Rowan. A scholar is included among the top collaborators of Karen Rowan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Rowan. Karen Rowan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowan, Karen. (2019). Hawai'i Journal Watch: >Highlights of recent research from the University of Hawai'i and the Hawai'i State Department of Health.. PubMed. 78(1). 103–103. 1 indexed citations
2.
Rowan, Karen, et al.. (2018). Toward a Model for Preparatory Community Listening. Community Literacy Journal. 13(1). 23–36. 1 indexed citations
3.
Rowan, Karen, et al.. (2011). Writing Centers and the New Racism: A Call for Sustainable Dialogue and Change. Digital Collections of Colorado (Colorado State University). 17 indexed citations
4.
Wartchow, Charles, Frank Podlaski, Shirley Xin Li, et al.. (2011). Biosensor-based small molecule fragment screening with biolayer interferometry. Journal of Computer-Aided Molecular Design. 25(7). 669–676. 107 indexed citations
5.
Rowan, Karen. (2010). Should Cetuximab Replace Cisplatin in Head and Neck Cancer?. JNCI Journal of the National Cancer Institute. 102(2). 74–78. 9 indexed citations
6.
Rowan, Karen. (2009). All the Best Intentions: Graduate Student Administrative Professional Development in Practice. ˜The œWriting center journal. 29(1). 1 indexed citations
7.
Rowan, Karen. (2009). Trastuzumab Before Breast Surgery? Large Trial Says Yes But Does Not Quell Debate. JNCI Journal of the National Cancer Institute. 101(7). 448–449. 1 indexed citations
8.
Rowan, Karen. (2009). Oncology's First Phase 0 Trial. JNCI Journal of the National Cancer Institute. 101(14). 978–979. 2 indexed citations
9.
Chu, Xin‐Jie, David Bartkovitz, Waleed Danho, et al.. (2005). Discovery of 1-amino-4-phenylcyclohexane-1-carboxylic acid and its influence on agonist selectivity between human melanocortin-4 and -1 receptors in linear pentapeptides. Bioorganic & Medicinal Chemistry Letters. 15(22). 4910–4914. 11 indexed citations
10.
Luk, Kin‐Chun, Mary Ellen Simcox, Karen Rowan, et al.. (2004). A new series of potent oxindole inhibitors of CDK2. Bioorganic & Medicinal Chemistry Letters. 14(4). 913–917. 41 indexed citations
11.
Danho, Waleed, Joseph Swistok, Lida Qi, et al.. (2003). Structure–Activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH2 at the human melanocortin-1 and -4 receptors: histidine substitution. Bioorganic & Medicinal Chemistry Letters. 13(1). 133–137. 22 indexed citations
12.
Danho, Waleed, Joseph Swistok, Lida Qi, et al.. (2003). Structure–activity relationship of cyclic peptide penta-c[Asp-His6-DPhe7-Arg8-Trp9-Lys]-NH2 at the human melanocortin-1 and -4 receptors: His6 substitution. Bioorganic & Medicinal Chemistry Letters. 13(7). 1307–1311. 9 indexed citations
13.
Sidduri, Achyutharao, Jefferson Tilley, Kenneth G. Hull, et al.. (2002). N-Cycloalkanoyl-l-Phenylalanine Derivatives as VCAM/VLA-4 Antagonists. Bioorganic & Medicinal Chemistry Letters. 12(17). 2475–2478. 8 indexed citations
14.
Sidduri, Achyutharao, Jefferson Tilley, Li Chen, et al.. (2002). N-Aroyl-l-Phenylalanine Derivatives as VCAM/VLA-4 Antagonists. Bioorganic & Medicinal Chemistry Letters. 12(17). 2479–2482. 15 indexed citations
15.
Trilles, Richard, et al.. (2002). Focused library approach for identification of new N-acylphenylalanines as VCAM/VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 12(12). 1679–1682. 15 indexed citations
16.
Chen, Li, Jefferson Tilley, Richard Trilles, et al.. (2002). N-Acyl-l-phenylalanine derivatives as potent VLA-4 antagonists that mimic a cyclic peptide conformation. Bioorganic & Medicinal Chemistry Letters. 12(2). 137–140. 21 indexed citations
17.
Chen, Li, Jefferson Tilley, Robert Guthrie, et al.. (2000). N-Benzylpyroglutamyl-l-phenylalanine derivatives as VCAM/VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 10(8). 729–733. 30 indexed citations
18.
Chen, Li, Jefferson Tilley, Richard Trilles, et al.. (2000). N-Acyl phenylalanine analogues as potent small molecule VLA-4 antagonists. Bioorganic & Medicinal Chemistry Letters. 10(8). 725–727. 19 indexed citations
19.
Wertheimer, Stanley J., et al.. (1995). Stromelysin expression in IL-1β stimulated bovine articular cartilage explants. Inflammation Research. 44(S2). S119–S120. 4 indexed citations
20.
Rowan, Karen, et al.. (1995). Degradation of bovine cartilage proteoglycanin vitro is enhanced by inhibition of nitric oxide synthase. Inflammation Research. 44(S2). S151–S152. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mary Pat Beavers Breakdown of academic impact, for papers by Thomas H. Marsilje Breakdown of academic impact, for papers by Dana Davis Breakdown of academic impact, for papers by Gary P. Hingorani Breakdown of academic impact, for papers by Stefan Jaroch Breakdown of academic impact, for papers by Geeta Patel Breakdown of academic impact, for papers by Christophe Henry Breakdown of academic impact, for papers by Vesna Schauer-Vukašinović Breakdown of academic impact, for papers by Philbert Lee Breakdown of academic impact, for papers by Heather M. Brechbuhl
Rankless by CCL
2026